Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy

Among patients with symptomatic obstructive HCM, aficamten monotherapy was superior to metoprolol monotherapy in improving peak oxygen uptake and hemodynamics and decreasing symptoms. (Funded by Cytokinetics; MAPLE-HCM ClinicalTrials.gov number, NCT05767346.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2025-08-30
DOI
https://doi.org/10.1056/nejmoa2504654
Citations
36
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
49.97

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy

Roberto Barriales‐Villa, Perry Elliott, Brian Lee Claggett, Stephen B. Heitner et al.
36 citations
New England Journal of Medicine
Cardiomyopathy and Myosin Studies
49.97
article

Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy

Roberto Barriales‐Villa, Perry Elliott, Brian Lee Claggett, Stephen B. Heitner, P. Christian Schulze, Ajith Nair, Amy Wohltman, Ozlem Bilen, Melissa Burroughs, Steen Hvitfeldt Poulsen, Anne M. Dybro, Andrew Z. Wang, Regina Sohn, Juan Pablo Costabel, Edileide de Barros Correia, Scott David Solomon, Martin S. Maron, Pablo García‐Pavía, Daniel Jacoby, Ahmad Masri, Fady I. Malik, Stuart Kupfer, Michael A. Fifer, Zi Michael Miao, Indrias Berhane, Sheila M. Hegde, Béla Péter Merkely, Michael E. Nassif, Amy Mann, Patricia Réant, Gregory D. Lewis, María Luisa Peña‐Peña, Neal K. Lakdawala
article en
36 citations

Abstract

Among patients with symptomatic obstructive HCM, aficamten monotherapy was superior to metoprolol monotherapy in improving peak oxygen uptake and hemodynamics and decreasing symptoms. (Funded by Cytokinetics; MAPLE-HCM ClinicalTrials.gov number, NCT05767346.).

New England Journal of MedicineVol. 393(10)
Semmelweis University (HU), Brigham and Women's Hospital (US), WellStar Health System (US), St Bartholomew's Hospital (GB), Harvard University (US), Emory University (US), Université de Bordeaux (FR), Oregon Health & Science University (US), Baylor College of Medicine (US), Aarhus University Hospital (DK), Spanish National Centre for Cardiovascular Research (ES), Centre Hospitalier Universitaire de Bordeaux (FR), Massachusetts General Hospital (US), Health Innovations (United States) (US), Hospital Universitario Puerta de Hierro Majadahonda (ES), Lahey Medical Center (US), Duke Medical Center (US), Saint Luke's Hospital (US), Cytokinetics (United States) (US), Instituto Dante Pazzanese de Cardiologia (BR), Atlanta VA Medical Center (US), Hospital Universitario Virgen del Rocío (ES), Instituto de Investigación Biomédica de A Coruña (ES), Instituto Cardiovascular de Buenos Aires (AR), University College London (GB), Friedrich Schiller University Jena (DE), University of Colorado Colorado Springs (US)
Cytokinetics
Zero hunger
Openalex Percentile: Top 0%
Cardiomyopathy and Myosin Studies
49.97
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.